Todays Report: Today, Alps Advisors Inc. cuts position of HCP Inc. (HCP)

Today, Alps Advisors Inc. cuts position of HCP Inc. (HCP)

Alps Advisors Inc. reduced its position in shares of HCP Inc. (NYSE:HCP) by 5.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 49,935 shares of the real estate investment trust’s stock after selling 3,118 shares during the period. Alps Advisors Inc.’s holdings in HCP were worth $1,895,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. LGT Capital Partners LTD. increased its position in HCP by 10.5% in the second quarter. LGT Capital Partners LTD. now owns 441,440 shares of the real estate investment trust’s stock valued at $15,618,000 after buying an additional 41,790 shares during the last quarter. Chevy Chase Trust Holdings Inc. increased its position in shares of HCP by 1.3% in the second quarter. Chevy Chase Trust Holdings Inc. now owns 401,212 shares of the real estate investment trust’s stock valued at $14,195,000 after buying an additional 5,206 shares in the last quarter. Exxonmobil Investment Management Inc. TX increased its position in shares of HCP by 6.7% in the second quarter. Exxonmobil Investment Management Inc. TX now owns 120,906 shares of the real estate investment trust’s stock valued at $4,278,000 after buying an additional 7,560 shares in the last quarter. DNB Asset Management AS increased its position in shares of HCP by 2.7% in the second quarter. DNB Asset Management AS now owns 37,966 shares of the real estate investment trust’s stock valued at $1,343,000 after buying an additional 1,000 shares in the last quarter. Finally, British Columbia Investment Management Corp increased its position in shares of HCP by 4.9% in the second quarter. British Columbia Investment Management Corp now owns 228,975 shares of the real estate investment trust’s stock valued at $8,101,000 after buying an additional 10,655 shares in the last quarter. Hedge funds and other institutional investors own 91.72% of the company’s stock.

HCP Inc. (NYSE:HCP) traded down 0.85% during trading on Friday, reaching $29.26. The company had a trading volume of 2,109,091 shares. HCP Inc. has a one year low of $22.87 and a one year high of $36.82. The company’s market capitalization is $13.69 billion. The firm’s 50 day moving average is $30.83 and its 200 day moving average is $32.82.

HCP (NYSE:HCP) last released its quarterly earnings data on Tuesday, November 1st. The real estate investment trust reported $0.72 earnings per share for the quarter, topping analysts’ consensus estimates of $0.71 by $0.01. The firm earned $654.30 million during the quarter, compared to analyst estimates of $634.11 million. HCP had a negative return on equity of 0.32% and a negative net margin of 1.16%. During the same quarter in the prior year, the company posted $0.79 earnings per share. On average, equities research analysts predict that HCP Inc. will post $2.74 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 25th. Stockholders of record on Thursday, November 10th will be paid a $0.37 dividend. This represents a $1.48 dividend on an annualized basis and a dividend yield of 5.06%. The ex-dividend date of this dividend is Tuesday, November 8th. HCP’s dividend payout ratio (DPR) is -1,850.00%.

HCP has been the subject of several analyst reports. Zacks Investment Research upgraded HCP from a “hold” rating to a “buy” rating and set a $41.00 target price for the company in a research note on Wednesday, October 5th. Vetr upgraded HCP from a “buy” rating to a “strong-buy” rating and set a $32.83 target price for the company in a research note on Monday. BTIG Research restated a “neutral” rating on shares of HCP in a research note on Tuesday, November 1st. Bank of America Corp. upgraded HCP from an “underperform” rating to a “neutral” rating and set a $38.50 target price for the company in a research note on Tuesday, October 4th. Finally, Stifel Nicolaus upgraded HCP from a “sell” rating to a “hold” rating and cut their target price for the stock from $33.00 to $31.00 in a research note on Wednesday, November 2nd. Four equities research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the stock. HCP presently has an average rating of “Hold” and an average target price of $34.33.

In other news, insider Darren A. Kowalske sold 2,250 shares of the company’s stock in a transaction dated Wednesday, August 31st. The stock was sold at an average price of $39.20, for a total value of $88,200.00. Following the completion of the transaction, the insider now owns 9,793 shares of the company’s stock, valued at $383,885.60. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Thomas D. Kirby sold 3,000 shares of the company’s stock in a transaction dated Wednesday, September 7th. The stock was sold at an average price of $40.24, for a total value of $120,720.00. The disclosure for this sale can be found here. 0.22% of the stock is owned by insiders.

HCP Company Profile

HCP, Inc (HCP) is a self-administered real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital.

Related posts

Leave a Comment